Literature DB >> 18423260

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.

Alan Menter1, Alice Gottlieb, Steven R Feldman, Abby S Van Voorhees, Craig L Leonardi, Kenneth B Gordon, Mark Lebwohl, John Y M Koo, Craig A Elmets, Neil J Korman, Karl R Beutner, Reva Bhushan.   

Abstract

Psoriasis is a common, chronic, inflammatory, multisystem disease with predominantly skin and joint manifestations affecting approximately 2% of the population. In this first of 5 sections of the guidelines of care for psoriasis, we discuss the classification of psoriasis; associated comorbidities including autoimmune diseases, cardiovascular risk, psychiatric/psychologic issues, and cancer risk; along with assessment tools for skin disease and quality-of-life issues. Finally, we will discuss the safety and efficacy of the biologic treatments used to treat patients with psoriasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18423260     DOI: 10.1016/j.jaad.2008.02.039

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  267 in total

1.  The burden of psoriatic arthritis: a literature review from a global health systems perspective.

Authors:  Seina Lee; Alan Mendelsohn; Evelyn Sarnes
Journal:  P T       Date:  2010-12

2.  A practical approach to screening psoriasis patients for therapy with biologic agents.

Authors: 
Journal:  J Clin Aesthet Dermatol       Date:  2008-09

3.  Is There a Potential Role for Anti-tumor Necrosis Factor Therapy in Patients with Human Immunodeficiency Virus?

Authors:  Jason J Emer
Journal:  J Clin Aesthet Dermatol       Date:  2009-04

Review 4.  Treatment algorithms for early psoriatic arthritis: do they depend on disease phenotype?

Authors:  William Tillett; Neil McHugh
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

Review 5.  Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature.

Authors:  Megan O Jacus; Vinay M Daryani; K Elaine Harstead; Yogesh T Patel; Stacy L Throm; Clinton F Stewart
Journal:  Clin Pharmacokinet       Date:  2016-03       Impact factor: 6.447

Review 6.  Hydrogel-Based Active Substance Release Systems for Cosmetology and Dermatology Application: A Review.

Authors:  Martyna Zagórska-Dziok; Marcin Sobczak
Journal:  Pharmaceutics       Date:  2020-04-26       Impact factor: 6.321

7.  How psoriasis patients perceive, obtain, and use biologic agents: Survey from an academic medical center.

Authors:  Faranak Kamangar; Leah Isip; Tina Bhutani; Madison Dennis; Misha M Heller; Eric S Lee; Hong Nie; Wilson Liao
Journal:  J Dermatolog Treat       Date:  2011-11-10       Impact factor: 3.359

Review 8.  Genetics of susceptibility and treatment response in psoriatic arthritis.

Authors:  Darren D O'Rielly; Proton Rahman
Journal:  Nat Rev Rheumatol       Date:  2011-11-08       Impact factor: 20.543

Review 9.  Effective Strategies for the Management of Pyoderma Gangrenosum.

Authors:  Heidi Goodarzi; Raja K Sivamani; Miki Shirakawa Garcia; Lisa N Wehrli; Hilary Craven; Yoko Ono; Emanual Maverakis
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-10       Impact factor: 4.730

Review 10.  Calcipotriol/Betamethasone Dipropionate Foam: A Review in Plaque Psoriasis.

Authors:  Esther S Kim; James E Frampton
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.